EUVIMEDEUVIMED entdecken
Crossref

Efficacy and Tolerability of a Revised Formulatio of Acidosalus® Suppositories in Haemorrhoidal Disease: A Randomized Comparative Clinical Study

Višnja Oreščanin, Rosa Ferınčevıć, Marina Ferınčevıć, štefica Findri-Guštek, Zrinka Mihalić

Current Perspectives on Medicinal and Aromatic Plants (CUPMAP) · 29.04.2026 · 9

DOI: 10.38093/cupmap.1837350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), online erschienen am 29.04.2026. Verfasst von Višnja Oreščanin und 4 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective / Purpose: This open-label, randomized comparative clinical study evaluated the efficacy and tolerability of the newly reformulated Acidosalus® hemorrhoidal suppositories in patients with Grade I–III haemorrhoidal disease, compared to Bioapifit® anti-haemorrhoidal ointment as an established comparator. Materials and methods: Acodosalus suppositories are applied rectally once a day (before bedtime) for 10 consecutive days. Bioapifit ointment applied externally three times a day onto clean perianal area and rectally once a day for 10 consecutive days. Symptoms (pain, defecation discomfort, bleeding severity, anal itching, and overall subjective discomfort) were assessed at baseline, Day 3, Day 5, and Day 10 of treatment using a standardized rating scale. Results: Symptom improvement was observed in both groups, with no statistically significant differences between treatments at any time point (all p>0.05). Ten days of the application of Acidosalus suppositories resulted in 89.6% reduction of pain, 91.3% defecation discomfort, 100% of bleeding, 91.7% of itching while overall subjective discomfort was reduced for 89.6% with clinical cure rate of 82.5%. In the end of the treatment Bioapifit ointment performed slightly but not significantly better with decrease of initial values between 97.5% and 100% with clinical cure rate of 82.5%. Comparison with historical data from a previous clinical study using the older Acidosalus® formulation demonstrated a highly similar clinical performance profile, confirming continuity of therapeutic effect. Conclusion / Discussion: By Day 10, Overall subjective discomfort reduction reached 89.6% and 97.5% in Acidosalus and Bioapifit group, respectively with no statistically significant difference between them. Both treatments were well tolerated, with no adverse events. The new Acidosalus® formulation maintained clinical efficacy which is slightly but not significantly better for all time points.

Zitieren

APA

Oreščanin, V., Ferınčevıć, R., Ferınčevıć, M., Findri-Guštek, Š., & Mihalić, Z. (2026). Efficacy and Tolerability of a Revised Formulatio of Acidosalus® Suppositories in Haemorrhoidal Disease: A Randomized Comparative Clinical Study. Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), 9. https://doi.org/10.38093/cupmap.1837350

Vancouver

Oreščanin V, Ferınčevıć R, Ferınčevıć M, Findri-Guštek Š, Mihalić Z. Efficacy and Tolerability of a Revised Formulatio of Acidosalus® Suppositories in Haemorrhoidal Disease: A Randomized Comparative Clinical Study. Current Perspectives on Medicinal and Aromatic Plants (CUPMAP). 2026;9. doi:10.38093/cupmap.1837350

BibTeX
@article{Oreanin2026,
  author = {Oreščanin, Višnja and Ferınčevıć, Rosa and Ferınčevıć, Marina and Findri-Guštek, štefica and Mihalić, Zrinka},
  title = {Efficacy and Tolerability of a Revised Formulatio of Acidosalus® Suppositories in Haemorrhoidal Disease: A Randomized Comparative Clinical Study},
  journal = {Current Perspectives on Medicinal and Aromatic Plants (CUPMAP)},
  year = {2026},
  volume = {9},
  doi = {10.38093/cupmap.1837350}
}
Kostenlos starten →